IBTA vs IONS · rev $342.4M vs rev $514.0M
Ibotta, Inc. (IBTA) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Ibotta, Inc. (IBTA) is a software - application company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported IBTA revenue for 2025-12-31 was $342.4M. Net income was $3.6M. Revenue was down 6.8% from 2024-12-31 to 2025-12-31. IBTA currently screens at market cap $764.6M.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
IBTA currently screens at market cap $764.6M. IONS currently screens at market cap $12.28B.
Not investment advice. Open the IBTA and IONS stock pages for the full models.
Not investment advice.